Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Select · Equity
$33.3219
+$0.3272 · +0.99%
· Aug 21, 4:00 PM ET
$33.3219
Previous close+$0.3272 · +0.99%
· Aug 21, 4:00 PM ET
$33.36
+$0.3653 · +1.11%
Regular session · ET · Market data may be delayed.
The State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) aims to replicate the total investment returns of the S&P Emerging ex-China BMI (referred to as the "Index"), before accounting for its fees and operational costs. This Index comprises a diverse range of large, mid, and small-capitalization companies from emerging markets, weighted by their market value. Notably, it specifically omits all companies domiciled in China. By excluding Chinese equities, XCNY offers investors a distinct avenue to manage their specific risk exposure to China, while still accessing the significant growth and capital appreciation opportunities present in other developing economies.
Fund assets
9.88M USD
Expense ratio
0.19%
NAV
$32.93
Average volume
549
Volume
232
Day range
$33.30 – $33.405
52-week range
$25.77 – $34.51
Previous close
$32.9947
Price change
1 day
+0.99%
1 month
+4.16%
3 months
+2.66%
Year to date
+18.58%
1 year
+25.98%
3 years
+32.55%
5 years
+32.55%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio composition
Fund income
Jun 22, 2026
Semiannual
Jun 22, 2026
Jun 26, 2026
$0.2763
Dec 22, 2025
Semiannual
Dec 22, 2025
Dec 29, 2025
$0.4693
Jun 23, 2025
Irregular
Jun 23, 2025
Jun 27, 2025
$0.2847
Dec 23, 2024
Irregular
Dec 23, 2024
Dec 30, 2024
$0.2577
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
